FY2025 · ended Dec 31, 2025 · Revenue $8.23B, +7.2% YoY · Filed Feb 20, 2026
Zimmer Biomet Holdings, Inc. (ZBH) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $8.2 billion and net income of $705.1 million. Free cash flow was $1.5 billion. As of Sep 30, 2026 it held $399.9 million in cash and investments and $7.5 billion in total debt.
Revenue (TTM)
$8.57B
+7.0% vs year-ago TTM
Net income (TTM)
$767.40M
-4.7% vs year-ago TTM
Operating cash flow (TTM)
$1.88B
Free cash flow (TTM)
$1.64B
EPS (TTM)
$3.95
-2.4% vs year-ago TTM
Dividend per share (TTM)
$0.96
+0.0% vs year-ago TTM
Shares outstanding
195.65M
-1.7% vs prior year
Net cash
$-7.10B
as of Sep 30, 2026
Operating margin
13.6%
FY 2026
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- ZBH (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Warsaw, IN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1136869
- Former names
- ZIMMER HOLDINGS INC (until Jun 8, 2015)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
- Cadre Holdings, Inc. CDRE
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $8.2B | $7.7B | $7.4B | $6.9B | $6.8B |
| Operating income | $1.1B | $1.3B | $1.3B | $696.3M | $860.3M |
| Net income | $705.1M | $903.8M | $1.0B | $231.4M | $401.6M |
| Diluted EPS | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 |
| Operating cash flow | $1.7B | — | — | — | $1.5B |
| Free cash flow | $1.5B | — | — | — | $1.4B |
| Total assets | $23.1B | $21.4B | $21.5B | $21.1B | $23.5B |
| Total liabilities | $10.4B | $8.9B | $9.0B | $9.0B | $10.8B |
| Stockholders' equity | $12.7B | $12.5B | $12.5B | $12.0B | $12.7B |
| Cash and investments | $591.9M | $525.5M | $415.8M | $375.7M | $378.1M |
| Total debt | $7.8B | $6.4B | $6.0B | $5.9B | $7.4B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Other events
|
Aug 5, 2026 | Aug 5, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
All 1012 Zimmer Biomet Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.